retatrutide weight loss phase 2 trial results clinical trials New 3 data just dropped 👀 Eli Lilly's reported average approaching 30%, with some patients Experimental drug Retatrutide shows promising

[10] [11] Always source any diluent from a reputable, pharmaceutical-grade supplier and verify its suitability for the intended use

Side effects dramatically improve by week 10 and become minimal by week 13

It belongs to a new class of drugs called triple hormone receptor agonists sometimes referred to as triagonists

A retrospective cohort studies using the TriNeX database found that GLP-1 RA therapy combined with insulin was associated with a higher risk of diabetic retinopathy (HR, 1.21

Studies show that patients who make the correct (healthy) lifestyle changes to lose weight during treatment do not gain that weight back

That means the benefits extend well beyond the scale